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ABSTRACT 
Increased attention has been given to the gut lately in a number of conditions, from 
maintaining health via the use of probiotics to treating Autism Spectrum Disorder. Parkinson’s 
Disease has a history with the gut starting with the Braak hypothesis, in which eminent 
researcher Heiko Braak observed that the spread of Parkinson’s (PD) seemed to occur along 
either olfactory or enteric neurons prior to reaching the substantia nigra in the midbrain, where 
the classical disease symptoms become evident. Though this finding was largely ignored at the 
time, the possibility of a gut origin for PD has received interest lately as a growing body of 
epidemiological and mechanistic research supports a gut-based influence. One key study showed 
that the presence of a toxin that induces oxidative stress in the intestine is capable of generating 
protein aggregates that spread to the brain and cause a PD-like pathology. The spread of protein 
aggregates from gut neurons to the brain has been corroborated in a number of studies. The open 
question, then, is what type of toxic triggers are capable of causing protein aggregation in the 
real world, and how do they cause protein aggregation in enteric neurons, which do not directly 
contact the intestinal lumen? We propose here that the enzyme Nox1 contributes to oxidative 
stress in the gut and eventually to the protein aggregation that can lead to PD via the generation 
of endogenous reactive oxygen species. Nox1 functions to generate superoxide radicals and is 
highly expressed in the colon. Knockdown of NOX1 in the brain has been shown to have a 
protective effect in a PD mouse model. To bridge a trigger in the intestinal lumen to protein 
aggregation in enteric neurons, we investigate a class of cells that contact both the intestinal 
lumen and enteric neurons, known as enteroendocrine cells. Finally, we conduct a small study to 
explore a possible toxic trigger, high fat diet.  
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INTRODUCTION 
Parkinson’s Disease (PD) is the second most common neurodegenerative disease, 
affecting about 1% of the population over 60 and then again to 4% for those over 80 (1). The 
disease is typically characterized by the progressive loss of dopaminergic neurons in a region of 
the brain known as the substantia nigra or “black substance” (2). Post-mortem analysis of PD 
brains reveals the only physical hallmark of the disease, insoluble inclusions known as Lewy 
Bodies present throughout affected brain regions (2). Patients with PD typically present with two 
of four cardinal symptoms of PD, which include resting tremor, bradykinesia, rigidity, and 
postural instability (2). The diagnosis of PD is made based on these symptoms, patient history, 
and the United Parkinson’s Disease Rating Scale (2).    
The etiology of PD is obscure. Overall, about 80-90% of PD cases are considered 
idiopathic, meaning that the cause is unknown, and the other approximately 10-20% of cases are 
linked to genetics (2). In certain cases, the environment seems to play the dominant role, and 
likely accounts for some of those “idiopathic” cases. For example, exposure to pesticides like 
rotenone and paraquat increase PD risk by about 70%, and these same pesticides are used in the 
lab to generate in vivo and in vitro models of PD since they can recapitulate many of the 
symptoms and molecular aspects of the disease (3). On the other hand, genetics can also play a 
major role. Autosomal dominant mutations in LRRK2 and autosomal recessive mutations in DJ-1 
often result in early-onset PD (2). Despite the many gene loci identified with PD risk and the 
cases where the environment is known to play a role, the explicit cause of PD in the majority of 
the cases is unknown.  
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Briefly, there is one protein that deserves special attention with respect to PD pathology: 
alpha synuclein (4). Alpha synuclein plays a central role in PD and is extensively studied. The 
interest for this protein is derived from the fact that it makes up a major component of Lewy 
Bodies, and causes early onset PD in a dose-dependent manner (4). That is, duplications in 
SNCA, the gene for alpha-synuclein, cause early onset PD, and triplications of SNCA result in 
even earlier onset PD (4). At the molecular level, alpha synuclein is thought to contribute to PD 
when it takes on a beta-sheet conformation instead of its usual alpha helix, which allows it to 
aggregate into toxic oligomers, while also inducing other alpha synuclein species to fold into 
beta sheets as well (4). For this reason, alpha synuclein aggregation is referred to as “prion-like” 
(4). In fact, not only does alpha synuclein spread in a prion-like fashion inside the cell, but it can 
propagate between cells too. One relatively recent study found that, when PD brains were grafted 
with stem cells, these new stem cells also developed alpha synuclein aggregates within a matter 
of years (5). 
Recently, mounting evidence has suggested a role for the gut in PD pathogenesis. The 
foundation for this hypothesis comes from several observations. First, non-motor symptoms of 
PD, namely constipation, pre-date the motor symptoms by several years (6). As a result, 
constipation is thought to indicate an early stage of PD pathology, presumably one in which 
enteric nerves have been damaged by the spread of the disease. Second, alpha synuclein 
aggregates have been shown to be able to propagate up the vagus nerve to the brain (6). Next, a 
large study found that patients that had undergone vagotomy were 50% less likely than controls 
to develop PD (6). Interestingly, the effect was noted only for truncal vagotomy (entire vagus 
nerve severed) and not for superselective vagotomy (only specific branches of the nerve severed) 
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(6). This research suggests what is known as “the gut hypothesis for PD”, which posits that a 
toxic insult in the intestines causes a change in enteric neurons that initiates alpha synuclein 
aggregation, the aggregates then spread in a prion-like fashion up the vagus nerve into the brain, 
and finally the alpha synuclein aggregates reach the substantia nigra (SN) and induce the motor 
symptoms that define the disease (6).  
In a parallel vein, it is also vital to consider the role that oxidative stress (OS) plays in PD 
pathology. OS plays a central role in the pathology of many neurodegenerative diseases, 
including PD (17). In PD specifically, the importance of OS can be illustrated by its core 
involvement in the major toxin models used to replicate PD pathology including Paraquat, 6-
OHDA, MPTP, and Rotenone (18,19). In addition, genetic forms of PD often have some 
relatedness to OS (18,19). For example, LRRK2 mutations are related to mitochondrial 
dysfunction, and DJ-1 is a quencher of reactive oxygen species (ROS) that is protective against 
6-OHDA (18,19). The mechanisms whereby OS would lead to dopaminergic cell death include 
damage to the ubiquitin-proteasome system, lipid peroxidation, DNA damage, protein damage, 
alpha synuclein aggregation, and mitochondrial dysfunction (20). There is then the problem of 
trying to discern whether OS causes or contributes to PD pathogenesis. The issue is that many of 
the toxic effects that can be mediated by OS can also cause OS themselves (20). Alpha synuclein 
aggregation, for example, results in the production of ROS that contributes to OS, which can 
then further contribute to alpha synuclein aggregation (19). Mitochondrial dysfunction results in 
ROS generation that can lend an OS environment, and this OS can then further cause 
mitochondrial damage (20). Still, OS is involved in most parts of the PD disease process, and 
seems feasible as a primary event that could initiate alpha synuclein aggregation and other 
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aspects of PD pathology, or at the very least contribute to disease susceptibility. A 2010 study 
showed that low doses of rotenone delivered intragastrically over long periods of time could 
generate alpha-synuclein aggregates in neurons that spread from the vagus nerve up to the SN in 
a mouse model (16). In this study, it is important to consider that rotenone, a mitochondrial 
inhibitor and potent inducer of OS, started at the intestinal lumen before diffusing into cells and 
somehow initiating alpha synuclein aggregation in neurons (16). There are no neurons directly 
lining the intestinal lumen (15).  
Though intestinal epithelial cells themselves are an unlikely candidate for initiators of PD 
pathology due to their fast turnover time, enteroendocrine cells (EECs) are an attractive choice 
(15). These cells are sparsely distributed throughout the intestinal tract, and line the intestinal 
lumen just like intestinal epithelial cells, and so are exposed to whatever environment is present 
there (15). EECs also have a much longer turnover time compared to intestinal epithelial cells, 
which is important because OS may take time to initiate alpha synuclein aggregation (15). 
Importantly, EECs express alpha synuclein (15). Lastly, EECs directly contact neurons, which is 
an essential feature if they are expected to initiate PD pathology that eventually spreads to the 
brain (15). Once alpha synuclein aggregates reach enteric neurons, it has already been 
established that alpha synuclein can spread up the vagus nerve to the brain (16). What is 
currently not known is how aggregates can get to enteric neurons from inside the intestinal 
lumen.  
As a prominent generator of OS that is highly expressed in intestinal epithelial cells, and 
a protein that has been previously implicated in PD, Nox1 seems like a plausible contributor to 
intestinal PD pathology (21). The Nox family of NADPH oxidases were among the first enzymes 
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discovered that generate ROS “intentionally,” and not simply as a byproduct of some other 
process like ATP production in mitochondria (21). Nox2 was the first isoform identified, where 
it was found to play a role in the respiratory burst and pathogen destruction by phagocytes (21). 
Today, there are a variety of Nox enzymes known with numerous roles in various tissues (21). 
Of the several Nox isoforms, Nox1 is highly expressed in the colon, where it was originally 
cloned (22). Namely, Nox1 is present in colon epithelial cells, and it confers these cells with the 
ability to produce superoxide (see Figure 1) (22). The role of superoxide generation in these 
intestinal epithelial cells is thought to either facilitate cell proliferation or act as part of the host 
response (22). With respect to the host response hypothesis, Nox1 expression is correlated with 
areas of increased bacterial colonization, and its expression is increased by exposure to 
interferon-gamma, lipopolysaccharide, and flagellins (22). Moreover, it was found that intestinal 
epithelial cells rapidly respond to commensal or pathogenic microbes with ROS, likely through a 
Nox1/Duox2 mediated pathway since these enzymes are highly expressed in intestinal epithelial 
cells (12).  
With respect to PD, Nox1 in the brain was implicated in PD pathology in a number of 
studies by our lab (23, 24, 25). In a rat 6-hydroxydopamine (6-OHDA) PD model, Nox1 
expression was shown to increase in the SN along with DNA oxidative stress (23). In a second 
study, Nox1 expression was found to increase in a paraquat (PQ) mouse model of PD, and Nox1 
inhibition protected Tyrosine Hydroxylase-positive neurons from death in the SN (24). Last, 
Nox1 knockdown in a PQ rat model of PD was sufficient to reduce Tyrosine Hydroxylase-
positive neuron cell death, OS, and alpha synuclein oligomers in the SN (25).  
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Finally, we investigated high fat diet (HFD) as a possible trigger for PD-related 
pathology in the gut. First, one study showed that PD patients have an increase in their overall 
caloric intake, with the most major change occurring with intake of fats (26). Next, in a 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD, mice fed a HFD had 
lower dopamine levels after treatment and more striatal neuron loss (27). In another study it was 
shown that mouse fed a HFD prior to being subject to a 6-OHDA model of PD had increased 
dopaminergic (DA) cell loss as well as increased oxidative stress in the SN (28). Fat intake on 
the whole has also been show to increase the amount of oxidative stress in the gut (29). 
Moreover, long-term ingestion of HFD leads to changes in the microbiome (30). A major study 
related the microbiome to PD by showing that, in an alpha synuclein overexpression model of 
PD in mice, PD motor symptoms were largely attenuated in germ-free mice (31). Additionally, 
the study found that microbiome transplant from PD-affected human donors exacerbated 
physical symptoms when compared to transplant from healthy donors in the overexpression 
mouse model (31). An overall schematic showing the proposed relationship between an intestinal 
trigger like HFD, Nox1, OS, and alpha synuclein aggregation is shown in Figure 2.  
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Figure 1: Depiction of Nox1 protein generating superoxide while oxidizing NADPH to 
NADP+. Also shown are the many subunits associated with Nox1. Cytosolic subunits 
NOXA1 and NOXO1 are required for superoxide generation. Image from Ma et al, 
Molecular Neurodegeneration 
xiv 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nox1 
 
Brain 
 
Oxidative 
Stress 
Trigger 
Nox1 
 
Intestinal 
Epithelial Cells 
 
Intestinal 
Epithelial Cells 
 
Enteric Neuron 
 
EEC 
 
Alpha Synuclein  
Aggregate 
 
Alpha Synuclein  
Aggregate 
 
Substantia 
nigra 
 
Alpha Synuclein 
Aggregate 
 
Vagus Nerve 
 
Intestine 
 
Figure 1: Schematic depicting proposed relationship between intestinal trigger, Nox1, OS, and alpha 
synuclein aggregation. Intestinal changes initiated by trigger cause EECs contacting the lumen to 
upregulate expression of Nox1. OS is generated as a result, initiating alpha synuclein aggregation within 
the EECs. Alpha synuclein aggregates spread from the EECs to enteric neurons contacting the EECs. 
From there, aggregates spread to the vagus nerve and finally to the substantia nigra. 
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RESULTS 
Nox1 and Alpha Synuclein Transcripts are Present in Young and Aged Mouse Colon 
Duodenum, ileum and colon tissues were collected from a 7-month old male mouse, a 7-
month old female mouse, and a 23-month old male mouse. After that, RNA was extracted using 
Trizol. cDNA was then synthesized from the RNA, and a Polymerase Chain Reaction (PCR) 
using the cDNA as template was carried out. Primers for Nox1, alpha synuclein, and GAPDH 
were used (Figure 3).  
This experiment was performed because age is the most significant risk factor for PD, 
and therefore the presence of Nox1 in aged mice would be helpful in building our hypothesis 
(32). In addition, oxidative stress is known to increase with age, and an upregulation in Nox1 
expression was shown to occur in response to a toxin that induces oxidative stress in the brain in 
a previous study by our lab (32, 25). This result suggests that Nox1 is present throughout the 
intestinal tract in mice of both 7 and 23 months of age. It also suggests that alpha synuclein is 
present in at least the colons of male and female mice of both 7 months and 23 months of age, 
but it is not consistently detectable in the ileum and duodenum of 7-month old mice. 
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• D = Duodenum 
• I = Ileum 
• C = Colon 
GAPDH 
a-SYN 
M-7mths F-7mths M-23mths 
Nox1 
Figure 3: PCR data from cDNA of Duodenum, Ileum, and Colon of 7-month old male mouse, 7-month old 
female mouse, and 23-month old male mouse.  
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Nox1 Protein is Present throughout the Intestines of Young and Aged Mice 
Intestinal tissues from duodenum, ileum, and colon were extracted from a 7-month old 
male mouse and a 23-month old male mouse. Immunohistochemistry (IHC) was then performed 
on these tissues using Nox1 as the primary antibody. A secondary antibody control, in which 
only secondary antibody and no primary antibody was used, was performed to establish 
background staining. Following IHC, 5x, 10x, and 40x images were taken of the tissues. 
Representative 10x images are shown below (Figure 4).  
The expectation was that Nox1 protein levels would be present throughout the intestinal 
tract, but that Nox1 expression would be highest in the colon. Moreover, we were expecting to 
see that Nox1 levels would be significantly greater in the colon of the aged mouse when 
compared to the young mouse. We were able to confirm that Nox1 is in fact expressed thoughout 
the intestinal tract of both young and aged mice, but it is unclear from this study if there is 
increased expression in the colon or in the intestines of aged mice.  
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Figure 4: IHC of Duodenum, Ileum, and Colon from a 7-month old male mouse mouse and a 23-month 
old male mouse. “2ab” indicates that only secondary antibody was used, which acted as a control for 
background staining.   
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STC-1 Cells Express Alpha Synuclein and Nox1 Transcripts 
STC-1 cells were treated with either Dimethyl sulfoxide (DMSO) (vehicle control), 
100nM of Rotenone or 500nM of Rotenone and collected after 48 hours. The cells then 
underwent RNA extraction, and cDNA was subsequently synthesized from the RNA. Finally, the 
cDNA was amplified via PCR using Nox1, alpha synuclein, and GAPDH primer sets (Figure 5).  
In a previous study by our lab, it was shown that N27 cells (rat dopaminergic neuron cell 
line) treated under similar conditions exhibited an increase in Nox1 and alpha synuclein 
transcript expression (25). It was unclear in the literature whether or not STC-1 cells express 
Nox1 transcripts. In this experiment, it appears that they do. We also observed in this trial that 
STC-1 cells express alpha synuclein transcripts, as had been previously reported.  
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Figure 5: PCR of alpha synuclein and Nox1 cDNA in STC-1 cells under DMSO, 100nM Rotenone and 500nM 
Rotenone after 48 hours.  
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Nox1 Protein Levels are Unchanged in the Intestinal Tissue of Young Mice Fed a HFD 
Seven mice fed a HFD for 24 weeks were compared to six age-matched mice fed a 
normal chow diet. Intestinal tissue was collected at the end of the 24 weeks and paraffin-
embedded. Tissue was then sliced using a microtome and dried onto a microscope slide to be 
used in IHC staining. Nox1 antibody was used as the primary antibody in this study.  5x, 10x, 
and 40x images were taken of DAB-stained slides following IHC. Representative 10x images 
from three control and three HFD mouse tissues are shown below (Figure 3). Image 
quantification was performed using ImageJ on the 10x images for each tissue.  
In this case, HFD was investigated as a possible trigger that could enhance Nox1 protein 
expression in a Nox1-mediated PD model. If HFD did act as a trigger, it would be expected that 
a significant increase in Nox1 expression could be observed, especially in the colon, where Nox1 
protein levels are the highest. It does not appear here that there was any change in Nox1 protein 
level expression in HFD intestinal tissues compared to controls.   
  
 
 
 
 
 
 
 
 
15 
xxii 
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Control   
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Figure 6: Representative micrographs from Nox1 staining of the intestinal tissues of three animals each in 
either a HFD or Control diet. Duodenum (top left), ileum (top right), and colon (center) sections are 
shown with animals in the Control diet group in the top row and animals in the HFD group in the bottom 
row.  
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MATERIALS AND METHODS 
STC-1 Cell Culture Maintenance 
 STC-1 cells (ATCC) were maintained above five passages in DMEM high glucose 
supplemented with 20% FBS. Cell splitting was achieved by first incubating cells with Trypsin-
EDTA (TE) for 1-2 minutes, inactivating the TE by addition of equal volume of culture media, 
and pelleting the cells by 5 minutes of centrifugation at 500xg. The supernatant was then 
aspirated and the pellet resuspended in 1ml of media. This cell suspension was then aliquoted in 
appropriate volumes to new culture dishes or the same dish for the desired amount of cell 
splitting.  
 
RNA Extraction  
 RNA extraction was performed using 500ul of Trizol reagent (Invitrogen) for STC-1 cell 
pellets and 1ml Trizol reagent for tissue samples. Cell pellets and tissue samples were 
homogenized by pipetting up and down using a p1000. A p200 was used if further dissociation 
was required. For the tissue samples, even after pipetting and prolonged incubation in Trizol, 
some material did not dissolve. In this case, samples were spun down as 12,000xg for 10 minutes 
at 4°C, and the supernatant was collected and transferred to a new 1.5ml tube. After that, the 
RNA extraction proceeded as described in the Invitrogen protocol. Following extraction, the 
RNA pellet was allowed to dry in a 1.5ml tube with the lid open for 20 minutes. Samples were 
resuspended in 30ul to 50ul DEPC-treated water depending on pellet size.  
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cDNA Synthesis 
 cDNA synthesis consisted of using the GenDEPOT amfiRivert cDNA Synthesis Platinum 
Master Mix. A mixture was prepared consisting of 1ug of RNA brought up to a volume of 9ul 
with DEPC water, 10ul of a 2X buffer, and 1ul of reverse transcriptase enzyme. The reaction 
mixture was then incubated in a thermocycler at the following conditions: 1 minute at 60°C, 5 
minutes at 25°C, 1 hour at 50°C, and 1 minute at 85°C.  
 
Polymerase Chain Reaction 
 PCR was carried out using the GenDEPOT amfiSure PCR Master Mix (2X). The total 
reaction volume used was 16ul, and it contained 8ul of the 2X Master Mix, 1ul of 10uM forward 
primer, 1ul of 10uM reverse primer, 1ul of template DNA and 5ul of PCR-certified water. 
Following amplification, DNA amplicons were analyzed via agarose gel electrophoresis. A 1.2% 
agarose gel with 0.5ug ethidium bromide per 1ml agarose was typically used, and the gel was run 
at 100V for approximately 30 minutes. Depending on the amount of samples involved, gels were 
either prepared to a volume of 75ml or 150ml. Following electrophoresis, agarose gels were 
imaged in a Gel Doc Easy Imager (Biorad) with 0.2 seconds of light exposure.    
 
Immunohistochemistry 
 Paraffin-embedded tissues were cut to 25 micron slices using a microtome and then 
placed on microscope slides. Tissue slices on slides were allowed to dry overnight. After that, 
slides were deparaffinized in 2 changes of xylene for 5 minutes each, followed by incubation in  
18 
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2 changes of 100% ethanol for 3 minutes each, 95% ethanol for 1 minute, and 80% ethanol for 1 
minute. All slides were then boiled at 95-100°C in Sodium Citrate Buffer (10mM Citric Acid, 
0.05% Tween 20, pH 6) for 30 minutes. The slides were then allowed to cool for 20 minutes, and 
then rinsed twice in PBS-T (PBS with 0.05% Tween 20) for 5 minutes each. Endogenous 
peroxidase blocking was achieved by incubating slides in 3% hydrogen peroxide in PBS for 5 
minutes. Slides were rinsed in PBS-T and then permeabilized in 0.2% Triton in PBS. Next, 
blocking was performed in a solution of 1% Bovine Serum Albumin (BSA) and 5% horse serum 
in PBS-T for 30 minutes. Samples were washed in PBS-T and then incubated in primary 
antibody overnight at 4°C in a humidifier. Primary antibody staining was performed using a 1:25 
dilution of Nox1 antibody serum (a gift from the lab of Yabe-Nishimura). The next day, samples 
were washed three times in PBS-T and secondary antibody coupled to biotin was applied for one 
hour. Slides were washed again with PBS-T and then slides were incubated in the Avidin-Biotin 
Complex Reagents (Vecta Stain) for 1 hour. The samples were washed in 0.1M PB and then 
DAB stain (0.7mg/1mL DAB in a solution of 30% hydrogen peroxide and 0.1M PB) was applied 
for 2 minutes to each samples, in set of three slides at a time. After that, all slides were 
dehydrated by immersing in dH2O for 5 minutes, 70% ethanol for 5 minutes, 80% ethanol for 5 
minutes, 90% ethanol for 5 minutes, and 2 changes of 100% ethanol or 5 minutes. The samples 
were then placed in xylene for 15 minutes and mounted on a coverslip using Permount. The 
coverslips were allowed to dry overnight before being visualized on a Leica microscope.  
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Aged Mouse Studies 
 Wild Type (WT) C57BL/6 mice were used in these studies, including a 7-month old male 
mouse, a 7-month old female mouse, and a 23-month old male mouse.  
 
High Fat Diet Treatment 
WT C57BL/6 mice were fed a 60% HFD for 24 weeks. All mice were 32 weeks (8 
months) old. Body weight and food intake for each mouse was monitored on a weekly basis. The 
control group in the study consisted of three females and three males, and the HFD group 
consisted of four females and three males.   
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DISCUSSION 
 It is difficult to come to any concrete conclusions with the data obtained here, as much of 
it needs to be repeated. However, the data seems to suggest that Nox1 transcripts and protein are 
in fact present throughout young and aged mouse colons. It also seems that alpha synuclein 
transcripts exist in STC-1 cells. Also in STC-1 cells is the suggestion that Nox1 transcripts 
exists. If this observation is proven to be true after repeated experiments, it would simplify our 
downstream in vitro experiments in that a co-culture of STC-1 cells and intestinal epithelial cells 
would not be necessary.  Finally, feeding mice a HFD does not appear to affect Nox1 protein 
levels in the intestinal tract. To confirm this, it may be necessary to further explore the 
functionality of ImageJ and find a way to measure staining in specific structures, as opposed to 
measuring overall staining.  
 The data shown here represent only the very beginning steps of a long study involving 
Nox1’s role as a mediator of gut pathology. As stated above, many more repeats of the data 
shown here will be needed. Also down the road, larger cohorts will be necessary to generate 
findings that are meaningful. Moreover, other experiments may be used, including western blots 
and qPCR, to evaluate differences in transcript and protein expression.  
Finally, in the future, we may continue to investigate HFD as a possible trigger for Nox1-
mediated PD pathology in the gut, despite its apparent lack of a connection to Nox1 in this initial 
study. More focus, however, will be devoted to investigating P. mirabilis as a possible mediator 
of gut pathology, based on the study by Choi et al (34).  
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